Nicotine - Older Adults (50+): Difference between revisions

No edit summary
No edit summary
Line 45: Line 45:
**Citation: Gandelman, J. A., Newhouse, P., & Taylor, W. D. (2018). Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression. Neuroscience & Biobehavioral Reviews, 84, 289–298. doi:10.1016/j.neubiorev.2017.08.0
**Citation: Gandelman, J. A., Newhouse, P., & Taylor, W. D. (2018). Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression. Neuroscience & Biobehavioral Reviews, 84, 289–298. doi:10.1016/j.neubiorev.2017.08.0
***Acknowledgement: Supported by NIH grants K24 MH110598 and CTSA award UL1TR000445 from the National Center for Advancing Translational Sciences.
***Acknowledgement: Supported by NIH grants K24 MH110598 and CTSA award UL1TR000445 from the National Center for Advancing Translational Sciences.
=Very Low Nicotine Content Cigarettes=
===2021: [https://pmc.ncbi.nlm.nih.gov/articles/PMC8372658/ Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young Versus Older Adult Smokers]===
*Note: "Older" adults were 25+ (Some, maybe all, were not in the age group this page is compiling information on.)
*These results indicate that an immediate reduction in nicotine would result in beneficial effects in both young and older adults. Young adults show less positive subjective effects of smoking following switching to VLNC cigarettes relative to older adults.
**Citation: Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Smith TT, Dermody S, Koopmeiners JS, Jensen JA, Strayer LG, Donny EC, Hatsukami D. Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young Versus Older Adult Smokers. Nicotine Tob Res. 2021 Aug 18;23(9):1559-1566. doi: 10.1093/ntr/ntab049. PMID: 33754156; PMCID: PMC8372658.
***Acknowledgements: The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration. Research supported by a grant from the National Institute on Drug Abuse and the Food and Drug Administration Center for Tobacco Products (U54DA031659; Donny/Hatsukami). Manuscript preparation supported by NCI K01CA189300 (PI Cassidy), K01DA047433 (Smith), and NIDA P50DA036114.


=See Also=
=See Also=